Subsidiary's Rights Offering Payment Date Postponed to May 15, 2026
-
Correction disclosure: Payment date for subsidiary Dong-il Interlining (DIV) rights offering postponed (from Apr 30, 2026 to May 15, 2026)
-
Reason: Delays at Vietnamese embassy and related authorities
-
Purpose: Debt repayment (2,979,600,000 KRW, USD 2,000,000 debt-to-equity conversion)
-
Other: 100% owned subsidiary, limited company (no shares issued), total debt USD 6,268,773.37, converting USD 2,000,000
KOSPI Filing Information
-
Filing: [Correction of Description] Decision on Paid-in Capital Increase (Major Management Matters of Subsidiary)
-
Company: GeneOne Life Science (011000)
-
Submission: GeneOne Life Science, Inc.
-
Receipt: 04-30-2026
-
Under KRX KOSPI Market Division